Sinovac Gets a Small Boost (SVA)

Posted in pre-market 
November 30th, 2009

Sinovac Biotech Ltd. (NASDAQ: SVA) is indicated higher this morning after the Chinese drug and biotech player was Reiterated as Overweight with an $11 target at Piper Jaffray.  At 8:17 AM EST we have only seen 8,000 shares trade and the gain is only 1.9% ahead of conference data,  Last week the company announced a joint venture to expand its human-use vaccine manufacturing and dvelopment capabilities.  That news was muted due to holidaylight volume trading.


Comments are closed